药理学
脂肪变性
脂肪性肝炎
医学
脂肪肝
非酒精性脂肪肝
肝硬化
氧化应激
疾病
生物信息学
药品
信号转导
肝病
药物发现
细胞信号
污渍
生物
脂质代谢
癌症研究
化学
三七
作者
X. He,Jiawen You,Yanyan Deng,Ying Hu,Shenglan Qi,Qian Li,Yunyi Yang,Xiaoxiao Qu,Yuxin Shao,Xinyi Fu,Siqi Yang,Zhiying Wang,Yunhao Li,Min Zheng,Wei Liu,Hongjie Yang,Guangbo Ge,Zheng Yao,Yanming He
标识
DOI:10.3389/fendo.2026.1772033
摘要
DXR effectively ameliorates MASH in a mouse model by reducing hepatic steatosis, inflammation, and oxidative stress. Its mechanism of action involves the suppression of lipid synthesis and the prevention of hepatocyte apoptosis, achieved by modulating key anti-inflammatory and antioxidant signaling pathways. Flavonoids (such as apigenin and quercetin) are identified as the key active ingredients in DXR responsible for activating Keap1/Nrf2 and PI3K/AKT signaling pathways.
科研通智能强力驱动
Strongly Powered by AbleSci AI